Ann Surg Oncol (2018) 25:1936–1942 https://doi.org/10.1245/s10434-018-6454-1 OR IG INA L A R TIC L E – BREA S T O NC OLOG Y 1 2 3 Lisa J. Findlay-Shirras, HBSc, MBBS , Oussama Outbih, BSc Med, MD , Charlene N. Muzyka, MSc , 3 4,5 6,7 Katie Galloway, MSc , Pamela C. Hebbard, MD, FRCSC , and Maged Nashed, MD, PhD, FRCPC 1 2 Department of General Surgery, University of Manitoba, Winnipeg, MB, Canada; Department of Family Medicine, University of Ottawa, Ottawa, ON, Canada; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada; Section of General Surgery, Department of General Surgery, University of Manitoba, Winnipeg, 5 6 MB, Canada; CancerCare Manitoba, Winnipeg, MB, Canada; Radiation Oncology, Department of Radiology, University of Manitoba, Winnipeg, MB, Canada; Department of Radiation Oncology, CancerCare Manitoba, Winnipeg, MB, Canada ABSTRACT the same variables remained statistically signiﬁcant on Introduction. Breast-conserving therapy is the standard of multivariable analysis. care for early-stage breast cancer. In the era of multi- Conclusions. Our results suggest that even in the absence modality therapy, the debate on the value of revision of ‘no ink on tumor’, the cancer size and grade in surgery for compromised margins continues, and high
Annals of Surgical Oncology – Springer Journals
Published: May 10, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera